PTGX logo

Protagonist Therapeutics, Inc. (PTGX) EV/EBITDA

EV/EBITDA:

262.99+9.45(+3.73%)
December 12, 2025

Summary

  • As of today, PTGX EV/EBITDA is 262.99, with a rise of +9.45 (+3.73%) during the most recent trading session on December 12, 2025.
  • Over the past year, PTGX EV/EBITDA has increased by +250.19 (+1954.61%).
  • PTGX EV/EBITDA is now at all-time high.

Performance

PTGX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherPTGXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

PTGX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day+3.7%+3.7%+3.4%
1M1 Month+13.8%+13.8%+12.4%
3M3 Months+127.5%+73.9%+62.0%
6M6 Months+170.6%+84.3%+69.3%
YTDYTD+3351.3%+177.0%+147.0%
1Y1 Year+1954.6%+176.9%+136.1%
5Y5 Years+2555.6%+748.9%+343.1%

PTGX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month262.99at high226.09+16.3%
3M3-Month262.99at high114.49+129.7%
6M6-Month262.99at high91.07+188.8%
1Y1-Year262.99at high6.83+3750.5%
3Y3-Year262.99at high-16.97+1649.7%
5Y5-Year262.99at high-27.68+1050.1%
All-TimeAll-Time262.99at high-27.68+1050.1%

PTGX EV/EBITDA History

DateValue
2025
262.99(+3351.3%)
2024
7.62(+170.0%)
2023
-10.88(-357.1%)
2022
-2.38(+77.7%)
2021
-10.69(-13.0%)
DateValue
2020
-9.46(-836.6%)
2019
-1.01(-46.4%)
2018
-0.69(+91.4%)
2017
-8.06(+10.1%)
2016
-8.97

FAQ

  • What is Protagonist Therapeutics, Inc. EV/EBITDA?
  • What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?
  • What is PTGX EV/EBITDA year-to-date change?
  • What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?

What is Protagonist Therapeutics, Inc. EV/EBITDA?

The current EV/EBITDA of PTGX is 262.99

What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high EV/EBITDA is 262.99

What is PTGX EV/EBITDA year-to-date change?

Protagonist Therapeutics, Inc. EV/EBITDA has changed by +255.37 (+3351.31%) since the beginning of the year

What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?

Over the past year, PTGX EV/EBITDA has changed by +250.19 (+1954.61%)
On this page